161 -4 (78) 2025 - Boltayeva M.M. - USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN ENTEROPATHY IN PATIENTS WITH RHEUMATOID ARTHRITIS

USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN ENTEROPATHY IN PATIENTS WITH RHEUMATOID ARTHRITIS

Boltayeva M.M. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Enteropathy is a common condition in patients with rheumatic diseases, which can develop secondarily due to the disease itself or drugs used in treatment. Patients with rheumatoid arthritis are one of the pressing problems of modern medicine. The prevalence and frequency of gastrointestinal inflammation in rheumatoid arthritis risk factors for chronic gastrointestinal disease (GIT) are more common than in diagnosed rheumatoid arthritis. As a result, early diagnosis of gastrointestinal inflammation in patients with rheumatoid arthritis has important clinical and prognostic significance. Also, the occurrence of chronic inflammation in rheumatoid arthritis primarily depends on the duration of the disease and the nature of the inflammation

Key words: Enteropathy, rheumatoid arthritis, dyspepsia, gastrointestinal tract, chronic enteritis

First page

904

Last page

909

For citation:Boltayeva M.M. - USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN ENTEROPATHY IN PATIENTS WITH RHEUMATOID ARTHRITIS//New Day in Medicine 4(78)2025 904-909 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

1. Болтаева М.М. Энтеропатическая комарбидность у больных ревматоидным артритом // Journal of applied medical sciences. – 2024. – Vol.07. – P. 56-63.
2. Ивашкин В. Т., Султанов В.К. Болезни суставов. Пропедевтика, дифференциальный диагноз, лечение. М., Литтерра, 2005, 259-276.
3. Игнатьев В.К., Везикова Н.Н. Ревматоидный артрит. Петрозаводск, Издательство ПетрГУ, 1997, 125.
4. Насонов Е.Л., Каратеев Д.Е., Балабанова Р.М. Ревматоидный артрит. В кн.: Ревматология. Национальное руководство. Под. ред. Е.Л. Насонова, В.А. Насоновой. М.: Гэотар-Медиа, 2018; с. 290-331.
5. Ивашкин В.Г. Патогенез гастропатии, обусловленной приемом нестероидных противовоспалительных препаратов Росс. журнал гастроэнтерологии. 1994. - №1. - С. 11-14.
6. Каратеев А.Е, Насонов Е.Л, Ивашкин В.Т и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации // Научно-практическая ревматология. – 2018. – 56 (Прилож). – С. 1–29.
7. Axmatovna M. S. et al. Peculiarities of the morphophenotype and characteristics of the physical performance of young football players and their relationship with the gaming amplitude // Academicia: an international multidisciplinary research journal. – 2021. – Vol. 11. – № 2. – P. 1381-1388.
8. Boltayeva M. M. Enteropatic comarbidity in patients with rheumatoid Arthritis // Journal of multidisciplinary bulletin. – 2024. – Vol.07. – P. 56-63.
9. Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications // J Pharm Pharm Sci. – 2013. – Vol.16(5). – P. 821–47.
10. Lubberts E. Th17 cytokines and arthritis // Semin. Immunopathol. – 2017. – Vol. 32, № 1. – P. 43–53.
11. Poudel D.R, Acharya P, Ghimire S, Dhital R, Bharati R. Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database // Pharmacoepidemiol Drug Saf. – 2017. – Vol.26(6). – P. 635–41.

    file

    download